Jim Cramer - Mad Money MyoKardia MYOK-Q COMMENT Oct 05, 2020

https://www.businesswire.com/news/home/20201005005381/en/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash Today, Bristol Myers announced it's buying MyoKardia (MYOK-Q) ifor US$13.1 billion cash. MyoKardia makes drugs to fight heart disease and heart conditions, including mavacamten, a drug for which they will file an application in Q1-2021. The stock has gotten really cheap. He loves this deal.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$220.340

Stock price when the opinion was issued

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase Insights

5i Research

Joe Terranova

Virtus Investment Partners

Jim Lebenthal

Cerity Partners

Shannon Saccocia, CIO, Boston Private

Boston Private

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money MyoKardia MYOK-Q COMMENT Oct 05, 2020

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals